These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1345300)

  • 1. [Envelope and membrane glycoproteins of Herpes simplex virus].
    Ramos-Kuri JM
    Rev Latinoam Microbiol; 1992; 34(1):23-31. PubMed ID: 1345300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of herpes simplex virus glycoproteins in the virus replication cycle.
    Rajcáni J; Vojvodová A
    Acta Virol; 1998 Apr; 42(2):103-18. PubMed ID: 9770079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate.
    Pertel PE; Fridberg A; Parish ML; Spear PG
    Virology; 2001 Jan; 279(1):313-24. PubMed ID: 11145912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus: receptors and ligands for cell entry.
    Spear PG
    Cell Microbiol; 2004 May; 6(5):401-10. PubMed ID: 15056211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
    Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
    Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different receptors binding to distinct interfaces on herpes simplex virus gD can trigger events leading to cell fusion and viral entry.
    Spear PG; Manoj S; Yoon M; Jogger CR; Zago A; Myscofski D
    Virology; 2006 Jan; 344(1):17-24. PubMed ID: 16364731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins.
    Ghiasi H; Bahri S; Nesburn AB; Wechsler SL
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1352-60. PubMed ID: 7775113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.
    Zarling JM; Moran PA; Burke RL; Pachl C; Berman PW; Lasky LA
    J Immunol; 1986 Jun; 136(12):4669-73. PubMed ID: 2423598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein variability in herpes simplex virus type 1 strains by radioimmunoprecipitation with monoclonal antibodies.
    al-Ahdal MN
    Microbios; 1993; 74(299):95-102. PubMed ID: 8395644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains.
    Chang YJ; Jiang M; Lubinski JM; King RD; Friedman HM
    Vaccine; 2005 Sep; 23(38):4658-65. PubMed ID: 15936852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
    Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G
    Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex viruses.
    Yasukawa M; Zarling JM
    J Immunol; 1985 Apr; 134(4):2679-82. PubMed ID: 2579149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in the antigenic structure of two major HSV-1 glycoproteins, gC and gB, influence immune regulation and susceptibility to murine herpes keratitis.
    Hendricks RL; Tao MS; Glorioso JC
    J Immunol; 1989 Jan; 142(1):263-9. PubMed ID: 2909617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexes between herpes simplex virus glycoproteins gD, gB, and gH detected in cells by complementation of split enhanced green fluorescent protein.
    Avitabile E; Forghieri C; Campadelli-Fiume G
    J Virol; 2007 Oct; 81(20):11532-7. PubMed ID: 17670828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.
    Roller DG; Dollery SJ; Doyle JL; Nicola AV
    Virology; 2008 Dec; 382(2):207-16. PubMed ID: 18950828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.
    Glorioso J; Kees U; Kümel G; Kirchner H; Krammer PH
    J Immunol; 1985 Jul; 135(1):575-82. PubMed ID: 2582051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model.
    Manservigi R; Boero A; Argnani R; Caselli E; Zucchini S; Miriagou V; Mavromara P; Cilli M; Grossi MP; Balboni PG; Cassai E
    Vaccine; 2005 Jan; 23(7):865-72. PubMed ID: 15603886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoproteins gG, gE, gI or the putative gJ.
    Balan P; Davis-Poynter N; Bell S; Atkinson H; Browne H; Minson T
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1245-58. PubMed ID: 8207391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.
    Rosenthal KL; Smiley JR; South S; Johnson DC
    J Virol; 1987 Aug; 61(8):2438-47. PubMed ID: 3037106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.